Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy ; volume:41 ; number:2 ; day:20 ; month:1 ; year:2023 ; pages:209-225 ; date:2.2023
PharmacoEconomics ; 41, Heft 2 (20.1.2023), 209-225, 2.2023
- Urheber
-
Rognoni, Carla
Falivena, Camilla
Costa, Francesco
Armeni, Patrizio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40273-022-01220-z
- URN
-
urn:nbn:de:101:1-2023040321223585654903
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rognoni, Carla
- Falivena, Camilla
- Costa, Francesco
- Armeni, Patrizio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-utility analysis of real-time artificial intelligent-assisted colonoscopy in Italy
Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy
Cost–utility analysis of a palliative care program in Colombia
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-utility analysis of real-time artificial intelligent-assisted colonoscopy in Italy
Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy
Cost–utility analysis of a palliative care program in Colombia
Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
Personalized use of ketamine and esketamine for treatment-resistant depression
Cost-utility analysis of real-time artificial intelligent-assisted colonoscopy in Italy
Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol
Cost-utility of tiotropium in patients with severe asthma
Cost-utility analysis of an implant treatment in dentistry
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing–remitting multiple sclerosis in Italy